For decades, rate control has been the preferred initial strategy in stable atrial fibrillation (AF) patients, given its simplicity and safety profile, while rhythm control has been reserved for patients with recent-onset AF, symptomatic instability, or anticipated long-term rhythm control. This has sparked an ongoing debate between both strategies. However, with the emergence of new and consistent evidence in recent years, early and continued rhythm control has been shown to benefit patients with AF. This CE will focus on the that data and review the updated guideline recommendations.